Infection
Journal Abbreviation: INFECTION
ISSN: 0300-8126
Publisher: Springer Verlag (Germany)
Publications (16)
No antibiotics for asymptomatic bacteriuria (2024)
Schnell A
Journal article, other
Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort (2024)
Tscharntke LT, Jung N, Hanses F, Koll CE, Pilgram L, Rieg S, Borgmann S, et al.
Journal article
Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON). (2024)
Appel KS, Nürnberger C, Förster C, Polidori MC, Kohls M, Kraus T, Hettich-Damm N, et al.
Journal article
Microbiologic diagnostics and pathogen spectrum in infective endocarditis of surgically treated patients: a five-year, retrospective, monocentric study (2023)
Ziegler R, Arnold H, Bertram R, Geißdörfer W, Pauschinger M, Fischlein T, Pollari F, Steinmann J
Journal article
Detection of pre-existing neutralizing antibodies against Ad26 in HIV-1-infected individuals not responding to the Ad26.COV2.S vaccine (2023)
Schmidt K, Harrer E, Schönau V, Simon D, Kleyer A, Steininger P, Korn K, et al.
Journal article
Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease (2021)
Pilgram L, Eberwein L, Wille K, Koehler FC, Stecher M, Rieg S, Kielstein JT, et al.
Journal article
Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning (2021)
Jakob CEM, Mahajan UM, Oswald M, Stecher M, Schons M, Mayerle J, Rieg S, et al.
Journal article
Role and benefits of infectious diseases (ID) specialists in the COVID-19 pandemics (2021)
Tscharntke L, Jung N, Rieg S, Spinner C, Hanses F, Borgmann S, Wille K, et al.
Conference contribution
SARS-CoV-2-seronegative HIV-1-infected subjects target CTL epitopes in the SARS-CoV-2 nucleoprotein cross-reactive to common cold coronaviruses (2021)
Schmidt K, Nganou-Makamdop K, Tenbusch M, El Kenz B, Maier C, Lapuente D, Überla K, et al.
Conference contribution
Update on the "Choosing Wisely" initiative in infectious diseases in Germany. (2020)
Draenert R, Jung N, Addo M, Berner R, Bickel M, Bogner JR, Cornely OA, et al.
Journal article, Review article